MiMedx Historical Income Statement
| MDXG Stock | USD 9.53 0.37 4.04% |
Historical analysis of MiMedx income statement accounts such as Other Operating Expenses of 169.4 M can show how well MiMedx Group performed in making a profits. Evaluating MiMedx income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of MiMedx's future profits or losses.
Financial Statement Analysis is much more than just reviewing and examining MiMedx Group latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether MiMedx Group is a good buy for the upcoming year.
MiMedx |
About MiMedx Income Statement Analysis
MiMedx Group Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to MiMedx shareholders. The income statement also shows MiMedx investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).
MiMedx Income Statement Chart
Add Fundamental
Interest Expense
The cost incurred by an entity for borrowed funds, including loans, bonds, or lines of credit.Other Operating Expenses
Other Operating Expenses is the expense which generally does not depend on sales or production quantities of MiMedx Group. It is also known as MiMedx overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. Expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production.Operating Income
Operating Income is the amount of profit realized from MiMedx Group operations after accounting for operating expenses such as cost of goods sold (COGS), wages and depreciation. Operating income takes the gross income and subtracts other operating expenses and then removes depreciation. Operating Income of MiMedx Group is typically a synonym for earnings before interest and taxes (EBIT) and is also commonly referred to as operating profit or recurring profit. Earnings before interest and taxes (EBIT), representing the amount of profit a company generates from its operations.Most accounts from MiMedx's income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into MiMedx Group current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in MiMedx Group. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in interest. At this time, MiMedx's Operating Income is most likely to increase significantly in the upcoming years. The MiMedx's current EBIT is estimated to increase to about 38.9 M, while Other Operating Expenses is projected to decrease to roughly 169.4 M.
| 2021 | 2023 | 2024 (projected) | Non Recurring | 53K | 47.7K | 45.3K | Reconciled Depreciation | 5.2M | 3.6M | 4.6M |
MiMedx income statement Correlations
Click cells to compare fundamentals
MiMedx Account Relationship Matchups
High Positive Relationship
High Negative Relationship
MiMedx income statement Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Net Income From Continuing Ops | (25.6M) | (49.3M) | (10.3M) | (30.2M) | 4.3M | 4.6M | |
| Net Income Applicable To Common Shares | (25.6M) | (83.3M) | (10.3M) | (36.8M) | (33.1M) | (31.4M) | |
| Tax Provision | (5K) | (12.3M) | 247K | 206K | 597K | 626.9K | |
| Reconciled Depreciation | 7.6M | 6.9M | 5.2M | 4.0M | 3.6M | 4.6M |
Currently Active Assets on Macroaxis
When determining whether MiMedx Group is a strong investment it is important to analyze MiMedx's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact MiMedx's future performance. For an informed investment choice regarding MiMedx Stock, refer to the following important reports:Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in MiMedx Group. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in interest. You can also try the Portfolio Volatility module to check portfolio volatility and analyze historical return density to properly model market risk.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of MiMedx. If investors know MiMedx will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about MiMedx listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.1) | Earnings Share 0.59 | Revenue Per Share 2.447 | Quarterly Revenue Growth 0.029 | Return On Assets 0.1838 |
The market value of MiMedx Group is measured differently than its book value, which is the value of MiMedx that is recorded on the company's balance sheet. Investors also form their own opinion of MiMedx's value that differs from its market value or its book value, called intrinsic value, which is MiMedx's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because MiMedx's market value can be influenced by many factors that don't directly affect MiMedx's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between MiMedx's value and its price as these two are different measures arrived at by different means. Investors typically determine if MiMedx is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, MiMedx's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.